Andromeda Surgical GTM brain

Andromeda Surgical is developing an AI-guided surgical robotics platform for urologists and hospitals, starting with prostate enucleation.

category

Surgical robotics for endourology

market profile

  • text: HoLEP for enlarged prostate is a demanding procedure with a steep learning curve, creating an opportunity for navigation and surgical assistance.
  • text: The company describes surgeon-in-the-loop autonomy as a development goal; its site says the product is available for sale only in Canada and New Zealand and website statements represent design goals.

personas

  • title: Urologist performing or learning HoLEP
    pains:
    • Learning complex endoscopic anatomy and technique can require substantial training
    • Surgeons need reliable orientation and control during prostate enucleation
  • title: Hospital urology service line director
    pains:
    • Expanding access to a difficult procedure depends on surgeon training and operating room capacity
    • New capital equipment requires credible clinical evidence and a practical integration plan
  • title: Hospital clinical engineering and procurement leader
    pains:
    • New robotic systems must fit surgical equipment, clinical workflows and local regulatory requirements
    • Purchasing decisions need evidence, service commitments and cost justification

icp

  • text: Hospitals and surgical centers in Canada and New Zealand with urology programs and demand for prostate procedures, subject to local product availability.
  • text: Academic or specialist urology centers evaluating HoLEP training, robotic assistance or clinical research are plausible early adopters.

message pillars

  • text: Start with intelligent navigation for endourology.
  • text: Design the interface around surgeon navigation and training.
  • text: Build toward an open platform with ongoing updates.

objections

  • objection: Is autonomous performance clinically proven and authorized in our market?
    response: Review indication-specific clinical evidence and local regulatory status; distinguish current capabilities from future design goals.
  • objection: Why change our current HoLEP workflow or invest in another robot?
    response: Assess a supervised demonstration, training burden, integration and total costs against the existing pathway.

competitors

  • name: PROCEPT BioRobotics
    why: AquaBeam offers a distinct robotic treatment for the same benign prostatic hyperplasia population.
  • name: Intuitive Surgical
    why: da Vinci is an established surgical robotics alternative for hospital urology investment, although it targets different procedures.
  • name: Medtronic
    why: Hugo RAS competes for broader urologic robotic surgery budgets rather than directly matching HoLEP.

influencers

  • name: Nick Damiano
    url: https://www.linkedin.com/posts/nickdamiano_i-spent-years-working-on-medical-devices-activity-7460362278152851456-M8Aa
    why: Co-founder and CEO discussing the company's surgical autonomy thesis.

keywords

  • robotic HoLEP
  • prostate enucleation robot
  • endourology surgical navigation
  • AI guided surgical robotics
  • benign prostatic hyperplasia robotic surgery
  • HoLEP training

voice

  • Visionary and technology-forward
  • Surgeon-centered
  • Aspirational about procedural access

signals

  • text: A urology department is building a HoLEP program or seeking to broaden surgeon training.
  • text: A hospital is evaluating surgical robotics or clinical collaborations in eligible markets.

stack

  • Richard Wolf endoscopic imaging and instruments
  • Quanta System holmium laser technology

pricing

model: unknown

motion

sales_led

channels

  • clinical partnerships
  • LinkedIn
  • industry press

confidence

medium

Founders

  • name: Nick Damiano
    title: Founder
    role: Founder
    bio: First YC medtech founder and only 2x YC medtech founder; Co-founder & CEO @ Andromeda Surgical S23; Founder & CEO @ Zenflow W15 - treated > 300 patients so far, Class 3 FDA approval, raised > $100M; Co-founder & CTO @ Avail MedSystems (f.k.a. Nurep, acq. by Mendaera) - launched in 1000 hospitals, raised $120M; Venture Partner @ Pioneer Fund; Stanford Biodesign Innovation Fellow & Stanford MS/BS; Generalist/SW engineer; Dad to two daughters; Semicolon enthusiast;
  • name: Kartik Tiwari
    title: Founder
    role: Founder
    bio: Background in robotics 3x technical founder, 2x YC founder Led the team at Starsky Robotics to become the first in the world to have a driverless truck on a public road

Back to YC companies